We are live on
!
Find out more
CAM
ClariVest Asset Management Portfolio holdings
AUM
$980M
1-Year Est. Return
60.89%
This Fund
S&P 500
This Quarter
Est. Return
-3.9%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$3.33B
AUM Growth
-$25.1M
(-0.75%)
Cap. Flow
+$188M
Cap. Flow
% of AUM
5.67%
Top 10 Holdings %
Top 10 Hldgs %
23.47%
Holding
694
New
77
Increased
265
Reduced
176
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$37.2M |
| 2 |
AT&T
T
|
+$29M |
| 3 |
D.R. Horton
DHI
|
+$29M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$28.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$28.5M |
| 2 |
Texas Instruments
TXN
|
+$28.3M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$18.8M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$18M |
| 5 |
Apple
AAPL
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.47% |
| 2 | Technology | 17.31% |
| 3 | Consumer Discretionary | 15.52% |
| 4 | Communication Services | 13.99% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Marcus Corp
MCS
$942M
| $691K | 0.02% |
35,693
+10,828
| +44% | +$212K |
|
302
Pathward Financial
CASH
$1.84B
| $683K | 0.02% |
49,026
-900
| -2% | -$13.8K |
|
|
SCNB
303
DELISTED
Suffolk Bancorp
SCNB
| $681K | 0.02% |
24,911
+10,711
| +75% | +$294K |
|
|
ENZ
304
DELISTED
Enzo Biochem, Inc.
ENZ
| $679K | 0.02% |
213,752
+960
| +0.5% | +$2.91K |
|
|
CYS
305
DELISTED
CYS Investments Inc.
CYS
| $671K | 0.02% |
92,451
+5,569
| +6% | +$43K |
|
|
CBR
306
DELISTED
CIBER Inc.
CBR
| $668K | 0.02% |
209,831
+1,200
| +0.6% | +$3.95K |
|
307
Kulicke & Soffa
KLIC
$4.8B
| $660K | 0.02% |
71,900
+4,500
| +7% | +$46.3K |
|
308
Provident Financial Services
PFS
$3.21B
| $657K | 0.02% |
33,700
+2,200
| +7% | +$42.2K |
|
309
HF Sinclair
DINO
$14.6B
| $642K | 0.02% |
13,127
+3,627
| +38% | +$173K |
|
310
Cirrus Logic
CRUS
$6.19B
| $631K | 0.02% |
20,020
-382
| -2% | -$11.7K |
|
|
SKUL
311
DELISTED
SKULLCANDY INC
SKUL
| $630K | 0.02% |
113,817
-798
| -0.7% | -$5.62K |
|
312
Insight Enterprises
NSIT
$4.59B
| $620K | 0.02% |
24,000
-47,378
| -66% | -$1.25M |
|
313
Halozyme
HALO
$12.1B
| $618K | 0.02% |
+45,991
| New | +$923K |
|
314
Harvard Bioscience
HBIO
$28.2M
| $616K | 0.02% |
16,276
-1,728
| -10% | -$80.4K |
|
315
Ford
F
$56B
| $614K | 0.02% |
+45,269
| New | +$647K |
|
|
DYN
316
DELISTED
Dynegy, Inc.
DYN
| $608K | 0.02% |
29,400
+1,800
| +7% | +$45.7K |
|
317
Comtech Telecommunications
CMTL
$51.8M
| $598K | 0.02% |
29,043
+100
| +0.3% | +$2.74K |
|
|
ADAM
318
Adamas Trust
ADAM
$885M
| $580K | 0.02% |
26,400
+1,600
| +6% | +$44.4K |
|
|
EMG
319
DELISTED
Emergent Capital, Inc.
EMG
| $572K | 0.02% |
+105,000
| New | +$560K |
|
|
MNK
320
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $567K | 0.02% |
8,868
-23
| -0.3% | -$2.28K |
|
|
PDLI
321
DELISTED
PDL BioPharma, Inc.
PDLI
| $558K | 0.02% |
110,788
-2,500
| -2% | -$14.3K |
|
322
Installed Building Products
IBP
$6.57B
| $549K | 0.02% |
+21,700
| New | +$586K |
|
|
EGIO
323
DELISTED
Edgio, Inc. Common Stock
EGIO
| $548K | 0.02% |
7,168
+195
| +3% | +$23.9K |
|
324
1st Source
SRCE
$2.13B
| $544K | 0.02% |
17,680
+1,180
| +7% | +$36.1K |
|
325
Wells Fargo
WFC
$264B
| $520K | 0.02% |
10,123
+9,959
| +6,073% | +$548K |
|
Similar funds
GCAC
D
PP
FTIS
AIA
SEC
AFG
ECM
ClariVest Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, ClariVest Asset Management held 694 positions worth $3.33B, down 0.75% from $3.35B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ClariVest Asset Management deployed $188M of net new capital in Q3 2015, opening 77 new positions and adding to 265 existing holdings. Its largest new stake was Edwards Lifesciences: 1,543,242 shares worth $36.6M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Discover Financial Services, an estimated $18M trimmed.
- ClariVest Asset Management's largest Q3 2015 buy was Edwards Lifesciences: 1,543,242 shares worth $36.6M.
- ClariVest Asset Management added most to Alphabet (Google) Class C in Q3 2015, an estimated $18.2M increase.
- ClariVest Asset Management's biggest Q3 2015 reduction was Discover Financial Services, cutting an estimated $18M.
- ClariVest Asset Management fully exited Capital One in Q3 2015, selling an estimated $28.5M.
- ClariVest Asset Management's ten largest holdings make up 23% of its $3.33B portfolio in Q3 2015.
- ClariVest Asset Management opened 77 new positions and closed 84 in Q3 2015.
- ClariVest Asset Management's portfolio value fell 0.75% quarter-over-quarter to $3.33B.
Based on ClariVest Asset Management's 13F filing for Q3 2015, filed 26 Oct 2015.